GPT Healthcare Q1 FY27 Results: Total Income Up 18% YoY to ₹128 Crore; PAT Up 65.7%

What Happened ?

GPT Healthcare Limited announced its Q1 FY27 unaudited financial results, reporting total income of ₹128.2 crore, up 18% YoY. EBITDA grew 38.5% YoY to ₹26.2 crore, with EBITDA margin expanding 300 bps to 20.4%. PAT surged 65.7% YoY to ₹12.7 crore, with PAT margin expanding to 9.9%. The company maintained competitive ARPOB at ₹42,350 while improving occupancy to 58.07% (excl. Raipur).

key details

• Total income up 18% YoY to ₹128.2 crore.
• EBITDA up 38.5% YoY to ₹26.2 crore; EBITDA margin expanded 300 bps to 20.4%.
• PAT up 65.7% YoY to ₹12.7 crore; PAT margin expanded to 9.9%.
• ARPOB maintained at ₹42,350 (competitive and affordable).
• Occupancy at 58.07% (excl. Raipur); overall occupancy at 45.5% (including Raipur).
• ILS Dum Dum: Completed 700+ renal transplants.
• ILS Howrah: Launched Robotic Knee Surgery programme (MAKO system).
• ILS Agartala: Delivered 700+ radiation therapy procedures.
• ILS Salt Lake: Surpassed 800 robotic surgeries.
• ILS Raipur: Received liver transplant license; expected to break even by Q3 FY27.
• Jamshedpur hospital on track for completion by Q4 FY27.
• Participation in BEMAKI acute kidney injury trial strengthened clinical research footprint.
• Seventh hospital in finalization process; expected to increase total capacity to 1,000+ beds.

Note:

• The company is in the process of finalizing its seventh hospital, which is expected to increase the network’s total capacity to more than 1,000 beds. Supported by standardized clinical governance and ongoing improvements in care quality, patient outcomes, and operational efficiency, these initiatives are expected to unlock operating leverage and deliver sustainable returns while preserving the company’s net-debt-free position.

Risk Analysis

Summary:

• While the company delivered strong Q1 performance with margin expansion, risks include occupancy ramp-up at new facilities, competition, and regulatory changes.

Key Risks:

• Occupancy ramp-up at Raipur and new facilities.
• Competition from other hospital chains in Eastern India.
• Regulatory changes in healthcare sector.
• Rising manpower and medical equipment costs.
• Integration and execution of expansion plans.
• Dependence on doctor and insurance networks.

Worst Case:

• Slower-than-expected occupancy ramp-up at new facilities or regulatory changes could impact revenue growth and profitability.

Risk Level: Low to Medium

Company Commentary

Management highlighted that:

• Dr. Om Tantia, Chairman, GPT Healthcare: “During the quarter, GPT Healthcare continued to advance its long-term growth strategy by improving occupancy across mature hospitals, progressively ramping up newer facilities, and strengthening its presence in underserved, high-density markets.”
• “The Company focused on expanding high-value specialties, introducing services aligned with patient demand, and increasing the adoption of robotic-assisted and minimally invasive procedures.”
• “It also strengthened its doctor and insurance networks, further enhancing patient access and supporting volumes during the period.”
• “In line with its capital-efficient expansion strategy, the Company is in the process of finalizing its seventh hospital, which is expected to increase the network’s total capacity to more than 1,000 beds.”
• “Supported by standardized clinical governance and ongoing improvements in care quality, patient outcomes, and operational efficiency, these initiatives are expected to unlock operating leverage and deliver sustainable returns while preserving the Company’s net-debt-free position.”